Lmr Partners LLP Blueprint Medicines Corp Transaction History
Lmr Partners LLP
- $9.66 Billion
- Q4 2024
A detailed history of Lmr Partners LLP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Lmr Partners LLP holds 2,600 shares of BPMC stock, worth $244,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,600Holding current value
$244,244% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
373Shares Held
65.1MCall Options Held
2.25MPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA6.77MShares$636 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$624 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$533 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$402 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$235 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.61B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...